Where has inflation gone?

The protracted weakness of inflation during the past cyclical upswing caught central banks and investors by surprise. There are several, partial explanations for this phenomenon, ranging from the impact of globalization, changes in the structure of goods and labor markets to the success of central banks to keep expectations in check.

Highlights:

  • The protracted weakness of inflation during the past cyclical upswing caught central banks and investors by surprise.
  • There are several, partial explanations for this phenomenon, ranging from the impact of globalization, changes in the structure of goods and labor markets to the success of central banks to keep expectations in check.
  • As the business cycle softens and the risk of “lowflation” reappears, central banks need to rethink their toolbox for a world where inflation is likely to be permanently lower than in the past and increasingly driven by expectations.
  • Sluggish inflation has raised fears of a “Japanification” of the US and especially euro area economies. However, we consider low inflation in Japan to be held up by special macro imbalances that do not apply to other countries.
  • Too low inflation dents profit margins and equity returns, and slows down the reduction in the real burden of debt, even though low interest rates help solvency in the short term.

Read the full publication below.

WHERE HAS INFLATION
GONE?

RELATED INSIGHTS

CHINA’S RECOVERY CONTINUED BUT A BIT SOFTER THAN EXPECTED
China's economic recovery continued in Q3 2020, although a bit softer than expected. Real GDP growth rose to 4.9% yoy, slightly below the Reuters consensus expectation of 5.2% yoy, but still a substantial upturn from the 3.2% yoy in Q2. On a quarterly base, growth dynamics softened to 2.7% qoq, after 11.7% qoq and -10% qoq in the two previous quarters.
Citywire video-interview with Peter Marber
Watch Peter Marber, fund manager of this global, non-directional, long/short approach to Emerging Markets debt, in a video-interview by Citywire.
COVID-19 FACTS & FIGURES
According to the IMF’s Managing Director, strong international cooperation on coronavirus vaccine could speed up the world economic recovery and add $9 trillion to global income by 2025. A WHO trial found that Remdesivir, Hydroxychloroquine, Lopinavir and Interferon have little or no effect on hospitalized Covid-19 patients. Gilead Sciences has questioned the findings of the WHO study saying data appeared inconsistent.